Harnessing the effector-to-regulatory T cell ratio to advance prognosis and precision therapy in pancreatic cancer.

Pancreatic cancer remains one of the most lethal malignancies, characterized by rapid progression, late-stage diagnosis, and resistance to current therapies. A major contributor to its poor prognosis is the highly immunosuppressive tumor microenviron…

Preview only. Read the full abstract at the source